NCT00160550View on ClinicalTrials.gov

Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures

PHASE3CompletedINTERVENTIONAL

Enrollment

154

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Generalized Convulsive Epilepsy

Interventions

DRUG

Levetiracetam

Sponsors

Lead Sponsor

All Listed Sponsors

lead

UCB Pharma

INDUSTRY

NCT00160550 - Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures | Biotech Hunter | Biotech Hunter